Cupric citrate hemipentahydrate 406 views0 applications

Australian Approved Name (AAN): Cupric citrate hemipentahydrate

Common names and synonyms: Dicopper 2-oxidopropane-1,2,3-tricarboxylate hemipentahydrate

Organic/Inorganic: Organic

Molecular formula: C6H4O7Cu2.2½H2O

Molecular weight: 360.24

Conversions (% mineral): 35.28

AI for copper as per NHMRC:
Infants – 0-6 months – 0.2mg/day
Infants – 7-12 months – 0.22mg/day
Children – 1-3 years – 0.7mg/day
Children – 4-8 years – 1.0mg/day
Boys – 9-13 years – 1.3mg/day
Boys – 14-18 years – 1.5mg/day
Girls – 9-13 years – 1.1mg/day
Girls – 14-18 years – 1.1mg/day
Men – 1.7mg/day
Women – 1.2mg/day
Pregnancy – 14-18 years – 1.2mg/day
Pregnancy – 19-50 years – 1.3mg/day
Lactation – 14-18 years – 1.4mg/day
Lactation – 19-50 years – 1.5mg/day

Maximum daily dose: The medicine must not contain more than 750 micrograms of Copper from Cupric citrate hemipentahydrate per the recommended daily dose OR the medicine must not contain more than 2.13 milligrams of cupric citrate hemipentahydrate per the recommended daily dose.

Warnings and restrictions: When for oral or sublingual use, copper is a mandatory component of Cupric citrate hemipentahydrate.

Allowable purpose of the ingredient: Active. Excipient. Homeopathic

TGA reference: Merck Index

Apply for this resource
Share this resource

Advanced Wellness Regulatory Solutions are a team of highly skilled professionals who specialise in providing timely and reliable regulatory and research & development advice.



While we take all measures to ensure that the information provided on this site is accurate, before relying on the material in any important matter, users should carefully evaluate its accuracy, completeness and relevance for their purposes, and should obtain any appropriate professional advice relevant to their particular circumstances.


Want to stay up to date with the latest industry changes and updates? Signup to our newsletter below.